Browsing COVID-19 Research by Publisher "Taylor and Francis"

Now showing items 1-4 of 4

    • A Biomarker Based Severity Progression Indicator for COVID-19: The Kuwait Prognosis Indicator Score. 

      Jamal, Mohammad H; Doi, Suhail A; AlYouha, Sarah; Almazeedi, Sulaiman; Al-Haddad, Mohannad; ... more authors ( Taylor and Francis , 2020 , Article)
      COVID-19 is a worldwide pandemic that is mild in most patients but can result in a pneumonia like illness with progression to acute respiratory distress syndrome and death. Predicting the disease severity at time of diagnosis ...

    • Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines 

      Fernandes, Queenie; Inchakalody, Varghese Philipose; Merhi, Maysaloun; Mestiri, Sarra; Taib, Nassiba; ... more authors ( Taylor and Francis , 2022 , Article)
      The emergence of novel and evolving variants of SARS-CoV-2 has fostered the need for change in the form of newer and more adaptive diagnostic methods for the detection of SARS-CoV-2 infections. On the other hand, developing ...

    • Occupational changes during the COVID-19 lockdown in Jordan 

      Malkawi, Somaya H.; Alqatarneh, Nisrin S.; Malkawi, Asma H.; Amro, Ahmad F.Saleem; Crowe, Terry K. ( Taylor and Francis , 2021 , Article)
      Background: Measures to limit the spread of COVID-19 have disrupted the lives of countless millions of individuals worldwide. Objective: To explore the experiences of occupational disruption and changing social roles among ...

    • Soluble ACE2 and angiotensin II levels are modulated in hypertensive COVID-19 patients treated with different antihypertension drugs. 

      A Elrayess, Mohamed; T Zedan, Hadeel; A Alattar, Rand; Abusriwil, Hatem; Al-Ruweidi, Mahmoud Khatib A A; ... more authors ( Taylor and Francis , 2022 , Article)
      This study examines the effect of antihypertensive drugs on ACE2 and Angiotensin II levels in hypertensive COVID-19 patients. Hypertension is a common comorbidity among severe COVID-19 patients. ACE2 expression can be ...